点击上面“蓝字”关注我们!本文来源于招财部落;如果喜欢,欢迎在文末处点个“在看”,感谢您的支持!最近减肥药赛道可真热闹,上个月辉瑞刚砸下100亿美元收购Metsera,如今又巨资锁定中国小分子减肥药。就在今晚,复星医药发布公告控股子公司药友制药、复星医药产业与辉瑞共同签订《许可协议》,将药友制药旗下口服小分子胰高血糖素样肽-1受体(GLP-1R)激动剂研药物YP05002及其相关产品的全球独家开发...
Source Link点击上面“蓝字”关注我们!本文来源于招财部落;如果喜欢,欢迎在文末处点个“在看”,感谢您的支持!最近减肥药赛道可真热闹,上个月辉瑞刚砸下100亿美元收购Metsera,如今又巨资锁定中国小分子减肥药。就在今晚,复星医药发布公告控股子公司药友制药、复星医药产业与辉瑞共同签订《许可协议》,将药友制药旗下口服小分子胰高血糖素样肽-1受体(GLP-1R)激动剂研药物YP05002及其相关产品的全球独家开发...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.